OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) is micro cap exploring the untapped potential of cannabis-derived pharmaceutical cures. There has been tremendous volatility in 2017 surrounding the shares of OWC Pharmaceutical Research Corp. (OTCMKTS:OWCP), a potential market leader in medical cannabis R&D. On a YTD basis, the stock is on fire, up 519.32% after teasing investors with announcements that its topical cream for psoriasis is showing very promising results.
However, it has hardly been a straight trajectory for the stock. In fact, investors seem like they’re getting whipsawed on a weekly, if not daily, basis. Yes, the stock is up more than 500% for the year, but over the past 30-day period, it’s down 16.15%. On February 27, the stock was trading at $2.70. Since then, OWCP hasn’t been able to find its footing. It’s now trading at $1.10, giving the company a stock market capitalization of $126.14 million.
Complicating matters is that OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) is at the cusp of two highly volatile industries – the biopharmaceutical industry and the cannabis industry. Put those two together, and you have a potent cocktail for volatility. Before you decide to invest in this stock, you really have to be willing to take a stance. Is this a traditional biopharmaceutical industry play? A cannabis momentum stock? Or is it something entirely new, a medical cannabis R&D play?
Find out when $OWCP stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
$OWCP 10-Day Chart Below:
What has investors chomping at the bit to get in on the ground floor is that the company seems to be showing some very promising clinical results for its cannabis-derived topical cream for psoriasis and other skin disorders. In one press release, the company touted the fact that the cream has resulted in up to 70% improvement in inflammation and proliferation associated with psoriasis. The company also announced that it was expanding the size and scope of its clinical trials to include other skin disorders.
When that announcement didn’t result in quite the boost expected, the company then followed up with an announcement stating that it was seeing “worldwide expression of interest” in its topical cream. That’s basically a clue to investors, telling them that this topical cream has the potential to be a real market blockbuster.
And, yet, given all that, shares of OWCP are still stuck around the $1 mark. Over the most recent 52-week period, shares have traded as low as $0.00 and as high as $3.23. So you can see the conundrum facing investors: this stock might be absolutely worthless, or it might have a tremendous amount of upside. If the stock dips below the $1 mark, it’s easy to see that the shorts might try to pile on and take this stock lower.
What’s needed is a better understanding of the company’s R&D operations. First of all, they aren’t based in the United States – they’re based in Israel. That makes some investors nervous. But there is a top-flight medical researcher team at OWCP, and all of their R&D research work is performed at acclaimed Israeli hospital and research institutions. What OWCP has said in the past is that it’s much easier to do cutting-edge research work on cannabis-derived substances in Israel than in the U.S. market. Which is why we’re seeing an Israeli company come up with a psoriasis treatment before anyone else.
In addition to the psoriasis cream, there are other products in the company’s R&D pipeline, including potential treatments for multiple myeloma, psoriasis and fibromyalgia. The company is also working on a cannabis soluble tablet delivery system. That should calm the nerves of any investors who think this is just a one-trick pony. There are plenty of products in the pipeline –it’s really just a matter of when they can make their way to market.
Based on all of the above, it’s easy to see how OWCP trading right around the $1 mark represents a truly unique buying opportunity. If you think there’s more reward than risk in this stock, this could be a huge opportunity to get in on a stock that’s already shown that it can rocket up at just about any time. For more news on OWC Pharmaceutical Research Corp. (OTCMKTS:OWCP), please subscribe to OracleDispatch.com below.